Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Charles & Colvard Ltd is a luxury goods business based in the US. Charles-and-Colvard shares (CTHR) are listed on the NASDAQ and all prices are listed in US Dollars. Charles-and-Colvard employs 51 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $1.28 |
|---|---|
| 52-week range | $1.17 - $3.48 |
| 50-day moving average | $1.36 |
| 200-day moving average | $2.20 |
| Wall St. target price | $2.00 |
| PE ratio | 3.8788 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.33 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.28 from 2022-07-01
| 1 week (2022-06-27) | -0.78% |
|---|---|
| 1 month (2022-06-03) | -11.11% |
| 3 months (2022-04-05) | -21.95% |
| 6 months (2022-01-05) | -54.61% |
| 1 year (2021-07-02) | -56.16% |
|---|---|
| 2 years (2020-07-02) | 82.28% |
| 3 years (2019-07-05) | 1.53 |
| 5 years (2017-07-03) | 40.35% |
Valuing Charles-and-Colvard stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Charles-and-Colvard's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Charles-and-Colvard's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Charles-and-Colvard shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Charles-and-Colvard's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.6 million.
The EBITDA is a measure of a Charles-and-Colvard's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $43.5 million |
|---|---|
| Operating margin TTM | 9.52% |
| Gross profit TTM | $18.6 million |
| Return on assets TTM | 4.12% |
| Return on equity TTM | 20.12% |
| Profit margin | 24.62% |
| Book value | $1.93 |
| Market capitalisation | $39.3 million |
TTM: trailing 12 months
We're not expecting Charles-and-Colvard to pay a dividend over the next 12 months.
Charles-and-Colvard's shares were split on a 5:4 basis on 30 January 2006. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Charles-and-Colvard shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Charles-and-Colvard shares which in turn could have impacted Charles-and-Colvard's share price.
Over the last 12 months, Charles-and-Colvard's shares have ranged in value from as little as $1.17 up to $3.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Charles-and-Colvard's is 0.387. This would suggest that Charles-and-Colvard's shares are less volatile than average (for this exchange).
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard. com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.